Coya Therapeutics (COYA)

• Market cap: $114M
• 1 day: -7.6%
• 5 days: -15.03%
• 1 month: -0.61%
• 3 months: 9.21%
• 6 months: 5.19%
• Year to date: -13.98%
• 1 year: -21.1%
• 5 years: 6.35%
• 10 years: 6.35%
• Sector: Healthcare
• Industry: Biotechnology

About: Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.

Employees: 8